Clinical Trial Update: The E-SERIES Registry for Supralimus® Coronary Stent for the Treatment of Unselected Patients With Coronary Lesions [Phase 4]

View source ↗

Summary

Phase 4 registry update for the Supralimus Coronary Stent in unselected patients with coronary lesions; the study status is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease

Drugs mentioned

• Supralimus Coronary Stent (coronary stent)

Snippet

Sponsor: Sahajanand Medical Technologies Limited | Conditions: Coronary Artery Disease | Phase 4 | Status: COMPLETED